LISA OSBUN: Open Payments
NPI 1295233575 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 6 payments from 6 companies in 2025. Trend: 2023 $89 · 2024 $800 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 1 | $136 |
| Dexcom, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $110 |
| AstraZeneca Pharmaceuticals LP | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $74 |
| Boston Scientific Corporation | 1 | $15 |
Products named: BRIUMVI, DEXCOM G7 GSS (161), Ozempic, SAPHNELO, HYQVIA, WaveWriter Alpha Prime 16.
Industry payments across TX — which companies pay providers there.
